These results agree with previous data reported that MDM2 antagonists induce reversible cell cycle arrest but not cell death in normal cells [8] and indicate that wild-type-p53 glioblastoma cells are more sensitive to nutlin-3a treatment than NHA. Here, TP53 is linked to glioblastoma.